The Coronary Risk Score in Women (CORSWO) can predict the risk of major adverse cardiovascular events (MACE), according to a ...

Results from the trial showed that Revascor reduced cardiovascular mortality and major adverse cardiovascular events. Credit: ...

Similar global trends were noted in ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. The investigators found the stroke, ischemic stroke, and intracerebral hemorrhage burdens ...

The paper compares the current peripheral transradial trajectory to that of the coronary space in the mid-2000s.

Windtree Therapeutics, Inc. has announced a new patent application for istaroxime derivatives, aimed at preventing or reducing the risk of acute myocardial arrhythmia. The filing builds on encouraging ...

Cigarette smoking from childhood into early adulthood is associated with an increased risk of premature cardiac injury, ...

Two-thirds of children who started tobacco smoking at 10 years of age continued until their mid-twenties, significantly ...

Researchers suggest an application to FDA may be made within the next 12 months, requesting approval to carry out a human clinical trial with the gene therapy.

The patent filing expands upon data obtained from animal model testing and the istaroxime human clinical trials in acute heart failure (AHF) and early cardiogenic shock (ECS), including the latest ...

Drinking sweetened beverages can increase cardiovascular disease risk, but occasionally savoring sugary refreshments doesn't ...

While surgery leads to more early bleeds and overall bleeds, PCI patients have more postdischarge events through 5 years.

Compared with a contemporary zotarolimus drug-eluting stent, a coronary bioadaptor system is noninferior among patients with CAD receiving PCI.